Search clinical trials for: Optimized background regimen

Total 1799 results

Otsuka Pharmaceutical Development & Commercialization...

Terminated

Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis

Tuberculosis

Latvia, Lithuania
National Institute of Allergy and Infectious Diseases...
Otsuka Pharmaceutical Development & Commercialization, Inc.

Recruiting

Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB

HIV Infections | Tuberculosis

Tanzania, India, South Africa, Botswana
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Tuberculosis, Pulmonary | Extensively Drug-Resistant Tuberculosis | Tuberculosis, Multidrug Resistant

Korea, Republic of, China, United States, Egypt, Estonia, Japan, Latvia, Peru, Philippines
Otsuka Pharmaceutical Development & Commercialization...

Completed

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

Multidrug Resistant Tuberculosis

Philippines, South Africa
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis

Tuberculosis | Rifampicin Resistant Tuberculosis

Brazil, India, South Africa, Tanzania, Thailand
Gilead Sciences

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance (CAPELLA)

HIV-1-infection

United States, Spain, France, Taiwan, Japan, Thailand, Dominican Republic, Germany, Canada, Italy, South Africa
ViiV Healthcare
Pfizer

Completed

Prospective Observational Epidemiologic Study of Maraviroc's Safety (POEM)

Human Immunodeficiency Virus

United States, Canada, Spain, Belgium, France, United Kingdom, Italy, Brazil, Puerto Rico, Germany, Greece
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Renal Denervation in Hypertension (DENER-HTN)

Hypertension, Resistant to Conventional Therapy | Renal Denervation

France
TaiMed Biologics Inc.
Westat

Completed

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

HIV

United States, Puerto Rico
TaiMed Biologics Inc.

Completed

Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV

HIV

United States, Taiwan, Puerto Rico
Myrexis Inc.

Terminated

A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

HIV Infections

Canada, United States
CytoDyn, Inc.

Completed

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140 (PRO140)

HIV

United States, Puerto Rico
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

HIV-1

United States, France, Spain, Portugal, Canada, United Kingdom, South Africa, Argentina, Brazil, Puerto Rico, Thailand, Netherlands, Romania
Otsuka Pharmaceutical Development & Commercialization...

Completed

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Pediatric | Multidrug Resistant Tuberculosis

Philippines, South Africa
United BioPharma

Not yet recruiting

UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients

HIV-1 Infection
Hoffmann-La Roche

Completed

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection

HIV Infections

France
San Gerardo Hospital

Completed

Near Infrared Spectroscopy (NIRS) and Superior Mesenteric Artery (SMA) Doppler Patterns as Predictor of Feeding Tolerance in Very Low Birth Weight (VLBW) IntraUterine Growth Restricted (IUGR) and NON IUGR Infants

Infant, Very Low Birth Weight | Infant Malnutrition | Feeding Disorder of Infancy or Early Childhood | Splanchnic Oximetry | Splanchnic Oxygenation

Italy
Boston University
National Institute of Allergy and Infectious Diseases (NIAID); Centers for... and other collaborators

Completed

Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (Opti-Q)

Tuberculosis, Multidrug-Resistant

South Africa, Peru
Merck Sharp & Dohme LLC

Completed

Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672) (VICTOR-E1)

HIV Infections
AstraZeneca

Recruiting

Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) (TOURMALINE)

Biliary Tract Cancer

France, Spain, Italy, Korea, Republic of, Japan, Germany, United States, Singapore
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Crohn Disease | Colitis, Ulcerative

United States, Hungary, Poland, Czechia, Japan, Belgium, Spain, Bulgaria, France, Italy, Slovakia, Austria
Janssen Research & Development, LLC

Recruiting

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB

Multidrug-Resistant Tuberculosis

Mozambique, Philippines, Russian Federation, South Africa, Uganda, Ukraine
Janssen Infectious Diseases BVBA

Completed

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Tuberculosis

China, Ukraine, Korea, Republic of, Peru, Estonia, Kenya, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey
Bamrasnaradura Infectious Diseases Institute
Department of Disease Control, Thailand

Completed

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure (BIDI-MONO)

HIV | AIDS | Treatment Failure | Lopinavir

Thailand
ViiV Healthcare
GlaxoSmithKline

Completed

PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

Infection, Human Immunodeficiency Virus I
Mayo Clinic

Completed

Environmental Factors to Increase Patient Comfort During Urodynamics Testing

Urologic Diseases | Lower Urinary Tract Symptoms

United States
University of California, Los Angeles
United States Agency for International Development (USAID); Ministry of Health... and other collaborators

Completed

Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners

HIV Infections

Malawi
Biotronik, Inc.

Completed

Interventricular Delay of Lumax HF-T for Heart Failure

Congestive Heart Failure

Switzerland, United States
University of Medicine and Pharmacy at Ho Chi Minh...

Completed

Comparing Efficacy of Optimal Treatment and Conventional Treatment for Major Depressive Disorder in Viet Nam

Major Depressive Disorder

Vietnam
University Hospital, Bordeaux

Completed

Impact of a Therapeutic Education Program of Patient on the Evolution of the Cardiovascular Chronic Disease (ETHEPAT)

Myocardial Infarction | Stroke

France
Hoffmann-La Roche
Trimeris

Completed

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

HIV Infections

United States, Canada, Puerto Rico
University Hospital, Caen

Recruiting

Haemodynamic and Respiratory Effects of a Low Positive End Expiratory Pressure Associated With a Fluid Challenge in Knee-chest Position (OPTIPEP)

Surgery

France
Centre Hospitalier Intercommunal de Toulon La Seyne...
Hamilton Medical AG

Recruiting

Patient-ventilator Synchronisation Study for Intensive Care Unit Patients (SyncAutoVNI)

Acute Respiratory Failure

France
Chang Gung Memorial Hospital
Kaohsiung Medical University

Recruiting

The Effects of Background Noise for Adult Patients' Sleep Quality in Intensive Care Unit.

Sleep

Taiwan
Carlo Chiesa
Associazione Italiana per la Ricerca sul Cancro

Recruiting

Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry (131THEROPT124)

Metastatic Differentiated Thyroid Cancer

Italy
University of Copenhagen
Herlev and Gentofte Hospital

Completed

Developing and Testing Delicious and Nutritious for the Old People

Quality of Life | Nutritional Deficiency | Physical Performance

Denmark
Hoffmann-La Roche

Completed

INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.

HIV Infections

France
University of North Carolina, Chapel Hill
Robert Wood Johnson Foundation

Completed

Designing Impactful Warnings for Sugary Drinks

Health Behavior

United States
Chongqing University Cancer Hospital

Recruiting

NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma by AJCC V8 Stage

China
Beijing Aerospace General Hospital

Completed

A Clinical Study of Optimized CT-guided Pulmonary Nodule Microcoil Localization Technique

Pulmonary Nodule, Solitary

China
Janssen Infectious Diseases BVBA

Completed

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

Tuberculosis

South Africa, Peru, Latvia, Philippines, Russian Federation, Thailand, Brazil, India
University Hospital, Montpellier

Completed

Impact of an Optimized Communication on the Readmission for Adverse Drug Event (URGEIM)

Adverse Drug Event

France
Duke University

Completed

Quality Improvement - Monitoring Alarm Optimization Study (QI-MAOS)

No Applicable Condition; Study of Physiologic Monitor Alarms
Beijing Children's Hospital

Unknown

Management Following Lumbar Puncture In Children (MFLPIC)

Spinal Puncture Complications
University of Texas at Austin

Unknown

Do Patients Perceive Surgeons Who Provide Personal Information as More Trustworthy and Empathetic?

Trust
Technological Centre of Nutrition and Health, Spain
Hospital Universitari Sant Joan de Reus; Fundació Eurecat; Europastry S.A.

Completed

Effect of Consumption of Bagel Without Palm Oil on Postprandial Lipidemia (PALMFREE)

Hyperlipemia

Spain
Hopital Foch

Terminated

Contribution of Connected Devices in the Follow-up of the Observance of a Prehabilitation Program (Prehab-Connect)

Surgery

France
University of Milan
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Valduce Hospital; Ente Ospedaliero... and other collaborators

Completed

Optimization of Ventilator Setting for Acute Exacerbations of Chronic Obstructive Pulmonary Disease (NIMV01AECB)

Acute Exacerbation of Chronic Obstructive Airways Disease

Italy, Switzerland
University of Utah

Terminated

Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy

Surgery | Myopia

United States
University of Calgary
Heart and Stroke Foundation of Canada

Unknown

Torsion Optimization to Reduce Symptoms and Improve Outcomes in Non-responders (TORSION)

Heart Failure, Congestive

Canada

Search clinical trials for: Optimized background regimen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations